XCSE
DAC
Market cap17mUSD
Oct 08, Last price
10.30DKK
1D
-1.90%
1Q
-1.90%
IPO
74.58%
Name
Danish Aerospace Company A/S
Chart & Performance
Profile
Danish Aerospace Company A/S designs, develops, manufactures, and sells medical monitoring and exercise equipment. It offers agile data analyzer and monitor, a medical software that supports loading data over a network connection; portable pulmonary function systems for use in the areas of respiratory, cardiovascular, and metabolic physiology; cycle ergometer with vibration isolation and stabilization system, a recumbent bicycle that provides aerobic exercise for the harmful physiological effects of exposure to microgravity; advanced respiratory monitoring systems; European enhanced exploration exercise devices; space shuttle ergometer; and flight ergometer, the next generation space ergometer. The company also provides respiratory monitoring systems-II equipment, a photo- and magnetoacoustic multi-gas analyzer for performing non-invasive cardiovascular and pulmonary measurements; and European gas delivery system, a specially developed gas cylinder used for calibration and measurement of equipment and/or as breathing gases for use in space. Danish Aerospace Company A/S was founded in 1988 and is based in Odense, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
Income | ||||||||
Revenues | 18,860 -40.84% | 31,881 33.33% | 23,911 17.48% | |||||
Cost of revenue | 6,669 | 27,839 | 6,078 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 12,191 | 4,042 | 17,834 | |||||
NOPBT Margin | 64.64% | 12.68% | 74.58% | |||||
Operating Taxes | (905) | 694 | 675 | |||||
Tax Rate | 17.18% | 3.79% | ||||||
NOPAT | 13,096 | 3,348 | 17,158 | |||||
Net income | (3,877) -291.97% | 2,020 8.32% | 1,865 963.85% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
Debt | ||||||||
Debt current | 13,424 | 15,662 | 4,906 | |||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | 1,220 | 1,166 | 1,126 | |||||
Net debt | 13,126 | 15,563 | 4,775 | |||||
Cash flow | ||||||||
Cash from operating activities | 4,393 | (8,944) | (6,371) | |||||
CAPEX | (18) | (36) | (1,112) | |||||
Cash from investing activities | (1,941) | (1,835) | (1,112) | |||||
Cash from financing activities | (2,238) | 10,756 | 4,906 | |||||
FCF | 41,494 | 5,462 | 7,789 | |||||
Balance | ||||||||
Cash | 297 | 84 | 106 | |||||
Long term investments | 15 | 24 | ||||||
Excess cash | ||||||||
Stockholders' equity | 4,961 | 12,052 | 21,306 | |||||
Invested Capital | 22,536 | 28,879 | 27,339 | |||||
ROIC | 50.94% | 11.91% | 73.91% | |||||
ROCE | 50.85% | 12.95% | 55.94% | |||||
EV | ||||||||
Common stock shares outstanding | 10,908 | 10,908 | 10,908 | |||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 12,708 | 4,539 | 18,601 | |||||
EV/EBITDA | ||||||||
Interest | 1,173 | 976 | 46 | |||||
Interest/NOPBT | 9.62% | 24.15% | 0.26% |